Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer Predicted by CD4+, CD8+, and FOXP3+ Tumor-Infiltrating Lymphocytes.

Primariadewi RustamadjiElvan WiyartaMeike PramonoSinta Chaira Maulanisa

Published in: Asian Pacific journal of cancer prevention : APJCP (2024)

This study shows that CD4+, CD8+, and FOXP3+ TIL have promising potential as predictive biomarkers. In particular, FOXP3+ is dominant in predictive models of pathological response in patients with IBC.

Keyphrases

neoadjuvant chemotherapy
regulatory t cells
locally advanced
lymph node
sentinel lymph node
dendritic cells
peripheral blood
radiation therapy
rectal cancer
risk assessment
early stage
young adults